Moschos SA - Search Results

1

The emerging field of venom-microbiomics for exploring venom as a microenvironment, and the corresponding Initiative for Venom Associated Microbes and Parasites (iVAMP).

Ul-Hasan S, Rodríguez-Román E, Reitzel AM, Adams RMM, Herzig V, Nobile CJ, Saviola AJ, Trim SA, Stiers EE, Moschos SA, Keiser CN, Petras D, Moran Y, Colston TJ. Ul-Hasan S, et al. Among authors: moschos sa. Toxicon X. 2019 Sep 20;4:100016. doi: 10.1016/j.toxcx.2019.100016. eCollection 2019 Oct. Toxicon X. 2019. PMID: 32550573 Free PMC article.

2

Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review).

Nitulescu GM, Paunescu H, Moschos SA, Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK, Drakoulis N, Tsatsakis A. Nitulescu GM, et al. Among authors: moschos sa. Int J Mol Med. 2020 Aug;46(2):467-488. doi: 10.3892/ijmm.2020.4608. Epub 2020 May 18. Int J Mol Med. 2020. PMID: 32468014 Free PMC article. Review.

3

A new threat from an old enemy: Re‑emergence of coronavirus (Review).

Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou M, Drakoulis N, Dumanov JM, Tutelyan VA, Onischenko GG, Aschner M, Spandidos DA, Calina D. Docea AO, et al. Among authors: moschos sa. Int J Mol Med. 2020 Jun;45(6):1631-1643. doi: 10.3892/ijmm.2020.4555. Epub 2020 Mar 27. Int J Mol Med. 2020. PMID: 32236624 Free PMC article. Review.

4

Predicting oligonucleotide therapeutic efficacy at the population level.

Theotokis PI, Usher L, Kortschak CK, Schwalbe E, Moschos SA. Theotokis PI, et al. Among authors: moschos sa. Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:182. Hell J Nucl Med. 2019. PMID: 31802060 Free article.

5

RACE-SEQ and Population-Wide Polymorphism Susceptibility Testing for Endonucleolytically Active, RNA-Targeting Therapeutics.

Usher L, Theotokis PI, Moschos SA. Usher L, et al. Among authors: moschos sa. Methods Mol Biol. 2019;2036:283-305. doi: 10.1007/978-1-4939-9670-4_17. Methods Mol Biol. 2019. PMID: 31410804

6

Measuring the Action of Oligonucleotide Therapeutics in the Lung at the Cell Type-Specific Level by Tissue Disruption and Cell Sorting (TDCS).

Graves H, Evans S, Fauler M, Frick M, Moschos SA. Graves H, et al. Among authors: moschos sa. Methods Mol Biol. 2019;2036:187-203. doi: 10.1007/978-1-4939-9670-4_11. Methods Mol Biol. 2019. PMID: 31410798

7

Extracellular vesicles and their nucleic acids for biomarker discovery.

Momen-Heravi F, Getting SJ, Moschos SA. Momen-Heravi F, et al. Among authors: moschos sa. Pharmacol Ther. 2018 Dec;192:170-187. doi: 10.1016/j.pharmthera.2018.08.002. Epub 2018 Aug 3. Pharmacol Ther. 2018. PMID: 30081050 Review.

8

A novel antifungal property for the Bacillus licheniformis ComX pheromone and its possible role in inter-kingdom cross-talk.

Esmaeilishirazifard E, Dariush A, Moschos SA, Keshavarz T. Esmaeilishirazifard E, et al. Among authors: moschos sa. Appl Microbiol Biotechnol. 2018 Jun;102(12):5197-5208. doi: 10.1007/s00253-018-9004-7. Epub 2018 Apr 23. Appl Microbiol Biotechnol. 2018. PMID: 29687141 Free article.

9

Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs.

Theotokis PI, Usher L, Kortschak CK, Schwalbe E, Moschos SA. Theotokis PI, et al. Among authors: moschos sa. Mol Ther Nucleic Acids. 2017 Dec 15;9:22-33. doi: 10.1016/j.omtn.2017.08.010. Epub 2017 Aug 24. Mol Ther Nucleic Acids. 2017. PMID: 29246301 Free PMC article.

10

Oligonucleotide Therapies for the Lung: Ready to Return to the Clinic?

Kumar M, Moschos SA. Kumar M, et al. Among authors: moschos sa. Mol Ther. 2017 Dec 6;25(12):2604-2606. doi: 10.1016/j.ymthe.2017.11.002. Epub 2017 Nov 23. Mol Ther. 2017. PMID: 29174842 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results